Biotech Kanazawa University research: How Cells Repair DNA’s Protective Barrier: A pathway to address a rare genetic disorder characterized by rapid aging in children December 11, 2024
Biotech Dizal Announces Positive Pooled Data of Sunvozertinib in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Published in Lung Cancer December 11, 2024
Biotech Resolution Therapeutics Announces Presentation at Keystone Symposia on Fibrosis December 10, 2024
Biotech Kling Biotherapeutics Strengthens Leadership Team to Advance Pipeline Using its Proprietary Primary B-Cell Selection and Evolution Platform December 10, 2024
Biotech Jacobio Pharma Presented preliminary Data on BET Inhibitor for Myelofibrosis at 2024 ASH December 9, 2024
Biotech Dizal Presents Latest Data of DZD8586, a LYN/BTK Dual Inhibitor, in B-cell Non-Hodgkin Lymphoma at the 2024 ASH Annual Meeting December 9, 2024
Biotech BLINCYTO® (BLINATUMOMAB) ADDED TO CHEMOTHERAPY SIGNIFICANTLY IMPROVES SURVIVAL IN NEWLY DIAGNOSED PEDIATRIC PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) December 8, 2024
Biotech Nektar Therapeutics Announces NKTR-255 Following CD19-directed CAR-T Therapy Enhanced Complete Response Rates in Patients with Relapsed or Refractory Large B-cell Lymphoma at the 66th Annual ASH Meeting December 8, 2024
Biotech Syndax Presents Positive Revuforj® (revumenib) Data in Acute Leukemias from Multiple Trials, Including the SAVE Combination and AUGMENT-101 Trials, at 66th ASH Annual Meeting December 8, 2024
Search
Biotech
December 11, 2024
December 11, 2024
December 10, 2024
December 10, 2024
December 9, 2024
December 9, 2024
December 9, 2024
December 8, 2024
December 8, 2024
December 8, 2024
